Advertisement


Vaccines
World  /  Published 02.12.20

UK approves Pfizer’s coronavirus vaccine

The United Kingdom on Wednesday gave emergency approval to Pfizer’s coronavirus vaccine, leaping ahead of the United States to become the first Western country to allow mass inoculatio...
By Benjamin Mueller in London

World  /  Published 02.12.20

Vaccine: UK nod for Pfizer

The UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, paving the way for mass vaccinations against the deadly novel coronavirus. The British regulator,...
By Our Bureau, Agencies in London

India  /  Published 02.12.20

Illness not related to vaccine: Govt

The neurological illness suffered by a clinical trial volunteer in Chennai after receiving the AstraZeneca-Oxford candidate vaccine was not related to the vaccine, senior health officials indicated on...
By G.S. Mudur in New Delhi

India  /  Published 01.12.20

Covid: damages for vaccine events

...
By G.S. Mudur in New Delhi

World  /  Published 01.12.20

Moderna seeks US, Europe approval

Moderna Inc will apply for US and European emergency authorisation for its Covid-19 vaccine on Monday after full results from a late-stage study showed it was 94.1 per cent effective with no serious s...
By Reuters in New York

India  /  Published 30.11.20

Modi meets vaccine developers, manufacturers

Prime Minister Narendra Modi on Monday held a virtual meeting with three teams working on developing and manufacturing Covid-19 vaccine and said they should take extra efforts to inform people in simp...
By Our Bureau, Agencies in New Delhi

India  /  Published 30.11.20

Experts point to troubling opacity in vaccine trials

...
By G.S. Mudur in New Delhi

India  /  Published 30.11.20

Sharma tweaks tweet after ‘confusion’

Sharma later clarified: “Regretting the error in our earlier tweet where the lines got misplaced, resulting in some avoidable confusion. The original tweet reads as follows: Prime Minister Naren...
By Our Special Correspondent in New Delhi

India  /  Published 29.11.20

SII rejects vaccine trial volunteer’s accusation

Vaccine major Serum Institute of India on Sunday rejected charges that AstraZeneca-Oxford's COVID-19 vaccine candidate has serious side effects and said it will seek damages in excess of Rs 100 cr...
By Our Bureau and Agencies in New Delhi

India  /  Published 29.11.20

DCGI probing ill-effect in trial

The Drugs Controller General of India and the institutional ethics committee at the implementation site are inspecting if the negative event as claimed to have been suffered by a Covid-19 vaccine volu...
By Our Bureau, Agencies in Chennai


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.